Skip to main content
. 2013 Mar 27;8:865–876. doi: 10.2147/IJN.S39951

Figure 9.

Figure 9

Line graph showing the effect of CGRP transgene on neurological scores.

Notes: The Tat-GS NP-pLXSN-CGRP-treated group had significantly improved neurological scores compared with the SAH and Tat-GS NP-pLXSN-treated groups. ***P < 0.001 versus Tat-GS NP-pLXSN-CGRP-treated groups.

Abbreviations: NPs, nanoparticles; SAH, subarachnoid hemorrhage; Tat-GS, Tat peptide-decorated gelatin-siloxane nanoparticles.